CLOs on the Move

Unibail-Rodamco-Westfield

www.urw.com

 
Unibail-Rodamco-Westfield is the premier global developer and operator of flagship shopping destinations, with a portfolio valued at €63.7 Bn as at June 30, 2018, of which 86% in retail, 8% in offices, 5% in convention & exhibition venues and 1% in services. Currently, the Group owns and operates 97 shopping centres, including 56 flagships in the most dynamic cities in Europe and the United States. Its centres welcome 1.2 billion visits per year. Present on 2 continents and in 13 countries, Unibail-Rodamco-Westfield provides a unique platform for retailers and brand events, and offers an exceptional and constantly renewed experience for ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.urw.com
  • 2049 Century Park East 41st Floor
    Los Angeles, CA USA 90067
  • Phone: 310.478.4456

Executives

Name Title Contact Details
Douglas Merkel
 Associate General Counsel Profile
Aline Taireh
 Executive Vice President and General Counsel Profile

Similar Companies

Project Associates Inc

Project Associates Inc is a Evansville, IN-based company in the Business Services sector.

Abbott Financial Group

Abbott Financial Group Inc. is a Jefferson City, MO-based company in the Business Services sector.

Aif Co

Aif Co is a Carson, CA-based company in the Business Services sector.

Biocartis

Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.

Final Offer

Final Offer is a platform that facilitates the offer and negotiation of residential real estate, providing a more transparent experience for buyers and sellers. It empowers top real estate agents to differentiate themselves and provide their clients wi...